More than 3,700 women have filed lawsuits against the company in the U.S., alleging harm from its permanent sterilization device Essure.
At a rally in Bronx, N.Y., Wednesday, Gov. Andrew Cuomo defended the Affordable Care Act and warned that Washington, D.C., is abandoning the middle class.
Piedmont Healthcare has agreed to take over and operate 27 Walgreens in-store clinics in the Atlanta metropolitan area. Piedmont joins systems in other states which have bought or leased retail clinics meant to provide fast, convenient care for patients with minor ailments.
Seventy-two percent of people responding to a survey said that they thought their care providers could easily transmit their medical histories.
Federal lawmakers from Florida are asking the Trump administration to junk a planned three-year demonstration in which beneficiaries need to get prior approval before they get home health services.
Larry Cash, the long-time chief financial officer at Community Health Systems, is retiring in May, the hospital chain announced Wednesday.
Epic Systems is trying to get providers' electronic health record systems connected through a new app program that uses Fast Healthcare Interoperability Resources, or FHIR.
A provision of the Affordable Care Act that requires providers to revalidate or recertify their Medicaid reimbursement eligibility has caused 65,000 providers to be stripped from the federal program, according to a Modern Healthcare analysis.
A fierce critic of Medicaid expansion has joined the White House team working on repealing and replacing the Affordable Care Act.
Thomas Meade, serial entrepreneur, is on to his fourth venture, Ohmx, a 20-employee company in Evanston, Illinois, that is developing electronic handheld devices to detect proteins such as those generated from heart attacks
Nationwide, in 2016, transplants hit a record high of nearly 34,000. That year, nine Illinois hospitals performed a collective 1,208 transplants, a 23 percent jump from 2015 and the most since 2009.
Today's roundup of technology, pharmaceutical and device news includes Gilead Sciences paying $125 million to Sarepta Therapeutics for a priority review voucher, a new patient advocacy group focused on drug prices launching, and more.